The results of this study also showed that P4/Org treatment can also inhibit the PKA/CREB pathway in mPRα knockdown lung adenocarcinoma cells, suggesting that other receptors were involved in addition to the mPRα‐mediated effects in this process. This evidence concerns the gene CREB1 and lung adenocarcinoma.